Beth joined CURE Epilepsy in March 2019 as its Chief Executive Officer. A strategic leader known for collaborative engagement, Beth has over 20 years of extensive experience within the epilepsy field and is driven by a strong passion for the needs, aspirations, and hopes of those impacted by epilepsy and their loved ones. Prior to joining CURE Epilepsy, Beth's professional experience included senior marketing roles at Lundbeck and Abbott Laboratories in addition to industry consulting. She has a strong track record of engaging with physicians, researchers, thought leaders, and patient advocacy groups in this sector. Beth has broad experience in neurology, diabetes, and rare diseases. She has led the commercialization efforts for multiple pharmaceutical products and has significant involvement with patient registries and specialty pharmaceutical distribution. Her spirit of volunteerism and her dedication to people with epilepsy is illustrated by her many years of partnering with advocates and nonprofits. Beth holds a Bachelor of Arts from Cornell College, a Master of Public Administration from Indiana University, and a Master of Business Administration from the University of Chicago.
